🔥Telegram İfşa

Michael Hufford of Lygenesis speaking on "From Science Fiction to FDA Submission: Ectopic Organoids and the Commercialization of Regenerative Medicine" at #Longevity2020 longevity2020.com

#FirstLongevity: More #news from us, as we announce our premier league Advisory Panel... #Longevity #longevitynews bit.ly/2CsTwXj Aubrey de Grey Greg Bailey João Pedro de Magalhães Dmitry Kaminskiy Lorraine Morley @RealMargaretta Michael Hufford george church Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs)

“It’s worth pointing out just how remarkable this is.” #LyGenesis’ Michael Hufford talks #Longevity #research programmes and #investment. #FirstLongevity bit.ly/3fQjD9s

So, we are keeping busy... LyGenesis announced today that 4 peer-reviewed papers have been published on our organ regeneration technology. Next up, a clinical trial for patients with end stage liver disease prnewswire.com/news-releases/… #youcangrowwhatwhere

A busy and productive year. Next up, a Phase 2a clinical trial of our cell therapy for patients with end stage liver disease... prnewswire.com/news-releases/…

What have we learned from setbacks and how to move the field forward post-COVID Hear from Michael Hufford Maddalena Adorno Dorian Therapeutics Natalia Novac Former Account of Eli Lilly and Company Wed 5th May 1600 BST Register for free bit.ly/3dT2ugH Part of the #Longevity Leaders Congress #ageing

LyGenesis in the news... forbes.com/sites/forbeste…

An important and thoughtful take on the tragic implications of our collective inability to reign in the costs of life-saving naloxone... filtermag.org/naloxone-narca…

This week on #TheIncrementalist Grow Your Own Organs, with Michael Hufford, CEO Lygenesis; discussion includes using the bodies own bio-reactor (lymph nodes) to grow replacement liver, recent FDA clearance to proceed to human trials, and more healthcarenowradio.airtime.pro

LyGenesis adds inborn #metabolism errors to drug pipeline... #LyGenesis adds orphan paediatric indications to its drug development pipeline with novel approach for treating patients with Maple syrup urine disease. #longevity #MSUD Michael Hufford #liver bit.ly/31WCk9k

Next we’re joined by Michael Hufford, CEO and co-founder of #LeGenesis as he discusses ‘Prometheus Unbound: From Myth to the Clinical Reality of Organ Regeneration’. #MILongevity #LongevityWeek

Prometheus Unbound: From Myth to the Clinical Reality of Organ Regeneration. Check out CEO, Michael Hufford's, talk at this years Investing in the Age of Longevity Conference youtube.com/watch?v=Tn4CH8…

Harm Reduction Therapeutics' Phase 1 clinical trial met its primary endpoints -- this successful milestone triggers work on a new drug application of a low cost, over-the-counter (OTC) intranasal naloxone product for FDA to review prnewswire.com/news-releases/…

A review of our recent progress using our cell therapy platform LyGenesis to regenerate organs... technologyreview.com/2022/08/25/105…

We are developing a pipeline of allogeneic cell therapies. Our platform leverages the lymph node as an in vivo bioreactor to grow functioning ectopic organs. #LymphNode #DrugDiscovery #Type1Diabetes #TissueRegeneration #OrganRegeneration #RegenerativeMedicine #cell #Allogeneic

OTC nalxone is one step closer... U.S. Surgeon General Dr. Robert M. Califf President Donald J. Trump Scott Gottlieb, MD 🇺🇸 Zachary Siegel Maia Szalavitz Dr. Nabarun Dasgupta prnewswire.com/news-releases/…

Many cell therapy approaches require genetic engineering that reprograms cells to fight a specific disease. Conversely, our allogeneic cell therapy platform does not involve genetic engineering, simplifying the regulatory and commercial pathway. #CellTherapy

Morphoceuticals is pleased to announce our seed funding for our programs using electroceuticals in limb regeneration and amputation stump health. bizjournals.com/boston/inno/st…

Over-the-counter Narcan will save lives, experts say. But the cost will affect access npr.org/2023/02/18/115…

Today, the FDA approved another over the counter naloxone nasal spray product – a medicine that reverses opioid overdoses and saves lives. Beating the opioid and overdose epidemic is a core pillar of my Unity Agenda. My Administration has committed unprecedented resources to